Envisia Therapeutics
AcquiredExtended-release drug delivery for eye disease
Research Triangle Park, United States · Founded 2013 · $41.5M raised
- Headquarters
- Research Triangle Park, North Carolina
- Employees
- 11–50
- Founded
- 2013
- Business Model
- B2B
- Website
- envisiatherapeutics.com
- Total Funding
- $41.5M
- Last Round
- $16.5M Extension RoundMar 2016
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Envisia Therapeutics is a clinical-stage biotechnology company based in Morrisville (Research Triangle Park), North Carolina, focused on developing novel sustained-release drug delivery platforms for ophthalmic diseases. The company's lead product, ENV515, is an extended-release travoprost implant for the treatment of open-angle glaucoma and ocular hypertension. Envisia employs engineered nanoparticle technology for both front-of-eye and back-of-eye drug delivery applications, and debuted with a $25 million Series A financing in November 2013.
Summary
Envisia Therapeutics is a Biotech company based in Research Triangle Park, United States, founded in 2013. It has raised $41.5M in total across 2 rounds, most recently a $16.5M Extension Round in Mar 2016. Investors include Canaan Partners, New Enterprise Associates and Pappas Capital.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Mar 2016
Sign up to see all 2 events
Funding: Series A through Extension Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/envisia-therapeutics"><img src="https://indexed.vc/api/badge/company/envisia-therapeutics" alt="Envisia Therapeutics on Indexed.vc" width="260" height="76" /></a>